Afirst Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 26-07-2024
- Paid Up Capital ₹ 0.20 M
as on 26-07-2024
- Company Age 35 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -25.39%
(FY 2023)
- Profit -38.99%
(FY 2023)
- Ebitda -80.38%
(FY 2023)
- Net Worth 12.65%
(FY 2023)
- Total Assets -25.19%
(FY 2023)
About Afirst Lifescience
The Corporate was formerly known as Magadh Electricals (I) Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Vinay Kumar and Dinesh Mishra serve as directors at the Company.
- CIN/LLPIN
U51505BR1989PTC003483
- Company No.
003483
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Afirst Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Kumar  | Director | 10-Sep-2011 | Current |
| Dinesh Mishra | Director | 25-Oct-2020 | Current |
Financial Performance of Afirst Lifescience.
Afirst Lifescience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.39% decrease. The company also saw a substantial fall in profitability, with a 38.99% decrease in profit. The company's net worth Soared by an impressive increase of 12.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Afirst Lifescience?
In 2023, Afirst Lifescience had a promoter holding of 58.08% and a public holding of 41.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Afirst Lifescience?
Unlock and access historical data on people associated with Afirst Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Afirst Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Afirst Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
